Welcome Guest | Register / Login

Biotechnology Market Research Reports

Sort By
Title Published Price Buy Now
GM-CSF Inhibitor - Pipeline Insight, 2019
By Delve Insight
"GM-CSF Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "GM-CSF Inhibitor development. The report provides detailed coverag...
Jan 2019 $ 1250
Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2019
By Delve Insight
"Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Gonadotro...
Jan 2019 $ 1250
G-Protein Coupled Receptor (GPCR) Agonist - Pipeline Insight, 2019
By Delve Insight
"G-Protein Coupled Receptor (GPCR) Agonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "G-Protein Coupled Receptor (GPCR) Agonist...
Jan 2019 $ 1250
Growth Hormone (GH) Agonist - Pipeline Insight, 2019
By Delve Insight
"Growth Hormone (GH) Agonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Growth Hormone (GH) Agonist development. The report pro...
Jan 2019 $ 1250
Growth Hormone Antagonist - Pipeline Insight, 2019
By Delve Insight
"Growth Hormone Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Growth Hormone Antagonist development. The report provide...
Jan 2019 $ 1250
Guanylate Cyclase (Guanyl Cyclase or Guanylyl Cyclase or GC) Activators - Pipeline Insight, 2019
By Delve Insight
"Guanylate Cyclase (Guanyl Cyclase or Guanylyl Cyclase or GC) Activators - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Guanylate C...
Jan 2019 $ 1250
Guanylate Cyclase-Coupled Receptor Activators - Pipeline Insight, 2019
By Delve Insight
"Guanylate Cyclase-Coupled Receptor Activators - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Guanylate Cyclase-Coupled Receptor Ac...
Jan 2019 $ 1250
H 4 Antagonist - Pipeline Insight, 2019
By Delve Insight
"H 4 Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "H 4 Antagonist development. The report provides detailed coverage of...
Jan 2019 $ 1250
Heat Shock Protein (Hsp) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Heat Shock Protein (Hsp) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Heat Shock Protein (Hsp) Inhibitor development. ...
Jan 2019 $ 1250
Hedgehog Signaling Pathway Antagonist - Pipeline Insight, 2019
By Delve Insight
"Hedgehog Signaling Pathway Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Hedgehog Signaling Pathway Antagonist develop...
Jan 2019 $ 1250
Hepcidin Antagonist - Pipeline Insight, 2019
By Delve Insight
"Hepcidin Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Hepcidin Antagonist development. The report provides detailed c...
Jan 2019 $ 1250
HIF-1 Alpha Inhibitor - Pipeline Insight, 2019
By Delve Insight
"HIF-1 Alpha Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "HIF-1 Alpha Inhibitor development. The report provides detail...
Jan 2019 $ 1250
Human Epidermal Growth Factor Receptor 4 (HER-4 or ErbB-4) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Human Epidermal Growth Factor Receptor 4 (HER-4 or ErbB-4) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Human Epiderma...
Jan 2019 $ 1250
Hypoxia Inducible Factor 1 (HIF-1) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Hypoxia Inducible Factor 1 (HIF-1) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Hypoxia Inducible Factor 1 (HIF-1) Inh...
Jan 2019 $ 1250
Hypoxia Inducible Factor Prolyl-4-Hydroxylase (HIF-PH) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Hypoxia Inducible Factor Prolyl-4-Hydroxylase (HIF-PH) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Hypoxia Inducible ...
Jan 2019 $ 1250
IkappaB Kinase (IKK) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"IkappaB Kinase (IKK) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "IkappaB Kinase (IKK) Inhibitor development. The repo...
Jan 2019 $ 1250
IL-6 Receptor Antagonist - Pipeline Insight, 2019
By Delve Insight
"IL-6 Receptor Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "IL-6 Receptor Antagonist development. The report provides ...
Jan 2019 $ 1250
Inducible Nitric Oxide Synthase (iNOS or Type II NOS) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Inducible Nitric Oxide Synthase (iNOS or Type II NOS) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Inducible Nitric Ox...
Jan 2019 $ 1250
Insulin Like Growth Factor (IGF) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Insulin Like Growth Factor (IGF) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Insulin Like Growth Factor (IGF) Inhibit...
Jan 2019 $ 1250
Insulin Like Growth Factor 1 (IGF-1) Activators - Pipeline Insight, 2019
By Delve Insight
"Insulin Like Growth Factor 1 (IGF-1) Activators - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Insulin Like Growth Factor 1 (IGF-1...
Jan 2019 $ 1250
Interleukin-10 (IL-10) Receptor Agonist - Pipeline Insight, 2019
By Delve Insight
"Interleukin-10 (IL-10) Receptor Agonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Interleukin-10 (IL-10) Receptor Agonist dev...
Jan 2019 $ 1250
Interleukin-12 (IL-12) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Interleukin-12 (IL-12) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Interleukin-12 (IL-12) Inhibitor development. The ...
Jan 2019 $ 1250
Interleukin-13 (IL-13) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Interleukin-13 (IL-13) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Interleukin-13 (IL-13) Inhibitor development. The ...
Jan 2019 $ 1250
Interleukin-17 (IL-17) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Interleukin-17 (IL-17) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Interleukin-17 (IL-17) Inhibitor development. The ...
Jan 2019 $ 1250
Interleukin-18 (IL-18) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Interleukin-18 (IL-18) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Interleukin-18 (IL-18) Inhibitor development. The ...
Jan 2019 $ 1250
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy